Recently, Tris Pharma said a recall had been issued for newborn ibuprofen sold by Family Dollar, CVS, and Walmart. The three retailers have dismissed lots of concentrated oral suspension and USP (NSAID) might have concentrations of ibuprofen, which are excessively high and therefore can be hazardous, according to the recall statement.
The OTC (over-the-counter) fever reducer and liquid pain reliever are used for infants who are amid the age of 6 Months and 23 Months old. Negative impacts from the medication might consist of vomiting, nausea, gastrointestinal pain, diarrhea, upper abdominal pain, ringing in the ears, and headache. Although according to Tris Pharma, no such events related to the dismissed ibuprofen have been reported yet. The recall statement stated, “There is an out-of-the-way possibility that infants, who might be more at risk to a higher effectiveness level of drug and therefore might be more susceptible to enduring NSAID-associated renal injury.” However, the recalled medications were in 0.5 Ounce bottles and sold across the nation through Family Dollar, CVS, and Walmart stores.
Lately, Walmart was also in news for turning to robots and apps in its stores. Walmart is turning to new technology to lower down costs and convince the customers to visit the stores. In recent times, Walmart declared it would get robotic floor scrubbers to almost 360 stores by the year-end. It also launched a new app—Dotcom Store—that permits associates to arrange products for customers on Walmart.com when the products are out of stock on the shelves. Both innovations synchronize to Walmart’s project to put up what CEO Doug McMillon called “technology-empowered provisions.” Over 3,500 US supermarkets are Walmart’s major advantage over Amazon, but they are costly to run. Walmart has over 704 million square feet of area to clean up across the country and the company thinks the robot janitor will help in saving time and ease up the workers to do other tasks around the store.